Actively Recruiting
HLA Antibodies in Systemic Lupus Erythematosus
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-01-16
30
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.
CONDITIONS
Official Title
HLA Antibodies in Systemic Lupus Erythematosus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults
- Patients followed in the internal medicine department of Amiens University Hospital with systemic lupus erythematosus
- No history of pregnancy, blood transfusions, or organ transplants
- Availability of stored blood samples in the biobank
You will not qualify if you...
- Patients under 18 years old
- Patients who do not consent to reuse of their personal data for research purposes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRU Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
N
Nicolas GUILLAUME, Pr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here